N,N-dimethyltryptamine (DMT) is a hallucinogen found endogenously in human brain that is commonly recognized to target the 5-hydroxytryptamine 2A receptor or the trace amine–associated receptor to exert its psychedelic effect. DMT has been recently shown to bind sigma-1 receptors, which are ligand-regulated molecular chaperones whose function includes inhibiting various voltage-sensitive ion channels. Thus, it is possible that the psychedelic action of DMT might be mediated in part through sigma-1 receptors. Here, we present a hypothetical signaling scheme that might be triggered by the binding of DMT to sigma-1 receptors.
Tsung-Ping Su, Teruo Hayashi and D. Bruce Vaupel; "When the Endogenous Hallucinogenic Trace Amine N,N-Dimethyltryptamine Meets the Sigma-1 Receptor"; Science Signaling, 10 March 2009 Vol 2 Issue 61 pe12; http://dx.doi.org/10.1126/scisignal.261pe12.
Transforming Medicine - The Role of MDMA in Mental Health Care [Palo Alto, CA]
24.10.2014 - 25.10.2014
[San Francisco] Grof Conference